Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,677.68
(
-0.31%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: poorgradstudent post# 109240

Friday, 05/20/2011 2:25:42 PM

Friday, May 20, 2011 2:25:42 PM

Post# of 257268
CHMP approves AMGN’s Xgeva for treatment of bone mets (i.e. prevention of skeletal-related events in patients with bone mets):

http://finance.yahoo.com/news/Amgen-Receives-CHMP-Positive-prnews-3364941121.html?x=0&.v=1

Rubber-stamping by the EU Commission will follow in 2-3 months.

Xgeva was approved in the US in this indication in Nov 2010 (#msg-56882220). AMGN plans to submit an sBLA for prevention of bone mets in CRPC during 1H11.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today